BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38328861)

  • 1. Anatomy of a crime: how IL7R and NRAS join forces to drive T-cell acute lymphoblastic leukemia.
    Barata JT
    Haematologica; 2024 Feb; 109(6):1637-9. PubMed ID: 38328861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia.
    Oliveira ML; Veloso A; Garcia EG; Iyer S; Pereira C; Barreto VM; Langenau DM; Barata JT
    Leukemia; 2022 Jun; 36(6):1533-1540. PubMed ID: 35581375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers.
    Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH
    Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
    Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
    Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low IL7R Expression at Diagnosis Predicted Relapse in Adult Acute Myeloid Leukemia Patients With t(8;21).
    Xu N; Sun K; Wang YZ; Chen WM; Wang J; Li LD; Wang X; Hao Y; Chang Y; Liu YR; Huang XJ; Qin YZ
    Front Immunol; 2022; 13():909104. PubMed ID: 35874754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
    Rozovski U; Li P; Harris D; Ohanian M; Kantarjian H; Estrov Z
    Cancer Med; 2014 Jun; 3(3):550-4. PubMed ID: 24678068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.
    Ott CJ; Kopp N; Bird L; Paranal RM; Qi J; Bowman T; Rodig SJ; Kung AL; Bradner JE; Weinstock DM
    Blood; 2012 Oct; 120(14):2843-52. PubMed ID: 22904298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
    Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
    Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
    Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
    Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Abdelrasoul H; Vadakumchery A; Werner M; Lenk L; Khadour A; Young M; El Ayoubi O; Vogiatzi F; Krämer M; Schmid V; Chen Z; Yousafzai Y; Cario G; Schrappe M; Müschen M; Halsey C; Mulaw MA; Schewe DM; Hobeika E; Alsadeq A; Jumaa H
    Nat Commun; 2020 Jun; 11(1):3194. PubMed ID: 32581241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
    Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
    Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
    Kim R; Boissel N; Touzart A; Leguay T; Thonier F; Thomas X; Raffoux E; Huguet F; Villarese P; Fourrage C; Passini L; Hunault M; Lepretre S; Chevallier P; Braun T; Lhéritier V; Chantepie S; Maury S; Escoffre M; Tavernier E; Chalandon Y; Graux C; Macintyre E; Ifrah N; Asnafi V; Dombret H; Lhermitte L;
    Leukemia; 2020 Jul; 34(7):1730-1740. PubMed ID: 31992840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
    Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
    Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
    Mansour MR; Reed C; Eisenberg AR; Tseng JC; Twizere JC; Daakour S; Yoda A; Rodig SJ; Tal N; Shochat C; Berezovskaya A; DeAngelo DJ; Sallan SE; Weinstock DM; Izraeli S; Kung AL; Kentsis A; Look AT
    Br J Haematol; 2015 Jan; 168(2):230-8. PubMed ID: 25256574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.
    Shochat C; Tal N; Bandapalli OR; Palmi C; Ganmore I; te Kronnie G; Cario G; Cazzaniga G; Kulozik AE; Stanulla M; Schrappe M; Biondi A; Basso G; Bercovich D; Muckenthaler MU; Izraeli S
    J Exp Med; 2011 May; 208(5):901-8. PubMed ID: 21536738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of co-operation of mutant
    Winer H; Li W; Rodrigues G; Gower T; Meyer TJ; Hixon J; Durum SK
    Haematologica; 2023 Nov; 109(6):1726-40. PubMed ID: 38031763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Noronha EP; Marques LVC; Andrade FG; Thuler LCS; Terra-Granado E; Pombo-de-Oliveira MS;
    Front Oncol; 2019; 9():316. PubMed ID: 31338319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.